Clinical Pearls

Clinical Pearls

Macrolides are not recommended as first line empiric therapy due to growing resistance rates for Streptococcus pneumoniae and Haemophilus influenzae

Fluoroquinolones should be reserved for only severe cases, failure of first-line options or in complicated cases due to the potential for increasing resistance, risk of Clostridium difficile infection and their importance in the management of other infections

Empiric therapy for atypical organisms (Mycoplasma pneumoniae & Chlamydophilia pneumoniae) not recommended

Consider systemic corticosteroids for moderate to severe exacerbations of COPD (prednisone 40 – 50 mg PO once daily for 5 days)

Influenza vaccination and pneumococcal vaccination recommended

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.